Ratios in Focus: Analyzing Biocryst Pharmaceuticals Inc. (BCRX)’s Price-to-Cash and Price-to-Free Cash Flow
In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation. In the latest session, Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) closed at $4.41 down -0.45% from its previous closing price of $4.43. In other words, the price has decreased […]
Biocryst Pharmaceuticals Inc. (BCRX) Decline -1.28% in Day Trading, Closes at $4.61
The price of Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) closed at $4.61 in the last session, down -1.28% from day before closing price of $4.67. On the day, 1979399 shares were traded. Ratios: We take a closer look at BCRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), […]
Biocryst Pharmaceuticals Inc. (BCRX)’s financial ratios: A comprehensive overview
After finishing at $4.60 in the prior trading day, Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) closed at $4.61, up 0.22%. In other words, the price has increased by $+0.0100 from its previous closing price. On the day, 1603502 shares were traded. Ratios: Our goal is to gain a better understanding of BCRX by taking a closer […]
Analyzing Biocryst Pharmaceuticals Inc. (BCRX)’s quick and current ratios
Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) closed the day trading at $4.69 down -7.13% from the previous closing price of $5.05. In other words, the price has decreased by -$0.3600 from its previous closing price. On the day, 3817836 shares were traded. Ratios: For a better understanding of BCRX, let’s look at its different ratios. For […]
Biocryst Pharmaceuticals Inc. (BCRX) Shares See Highest Trading Level at $4.91
The closing price of Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) was $4.91 for the day, down -2.00% from the previous closing price of $5.01. In other words, the price has decreased by -$0.1000 from its previous closing price. On the day, 2828298 shares were traded. BCRX stock price reached its highest trading level at $5.0800 during […]
Analyzing Biocryst Pharmaceuticals Inc. (BCRX)’s financial ratios for investment purposes
As of close of business last night, Biocryst Pharmaceuticals Inc.’s stock clocked out at $5.07, up 1.40% from its previous closing price of $5.00. In other words, the price has increased by $+0.07 from its previous closing price. On the day, 3760961 shares were traded. BCRX stock price reached its highest trading level at $5.18 […]
Biocryst Pharmaceuticals Inc. (BCRX)’s EPS estimates by 9 analysts
As of close of business last night, Biocryst Pharmaceuticals Inc.’s stock clocked out at $5.32, down -2.03% from its previous closing price of $5.43. In other words, the price has decreased by -$0.11 from its previous closing price. On the day, 2948311 shares were traded. Ratios: To gain a deeper understanding of BCRX’s stock, we […]
Comparison of current and last year’s EPS for Biocryst Pharmaceuticals Inc. (BCRX)
The closing price of Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) was $5.41 for the day, down -1.81% from the previous closing price of $5.51. In other words, the price has decreased by -$0.10 from its previous closing price. On the day, 1933157 shares were traded. Ratios: Our analysis of BCRX’s different ratios will help us gain […]
Biocryst Pharmaceuticals Inc. (BCRX)’s financial ratios: A comprehensive overview
In the latest session, Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) closed at $5.79 up 1.40% from its previous closing price of $5.71. In other words, the price has increased by $+0.08 from its previous closing price. On the day, 4004748 shares were traded. Ratios: For a deeper understanding of Biocryst Pharmaceuticals Inc.’s stock, let’s take a […]